Insider Buying: ASP Isotopes (NASDAQ:ASPI) Director Purchases $21,600.00 in Stock

Posted by on Sep 30th, 2026

ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) Director John Ryan purchased 8,000 shares of the company’s stock in a transaction that occurred on Monday, September 28th. The shares were bought at an average cost of $2.70 per share, with a total value of $21,600.00. Following the transaction, the director directly owned 660,222 shares of the company’s stock, valued at $1,782,599.40. The trade was a 1.23% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

ASP Isotopes Stock Performance

ASP Isotopes stock opened at $2.63 on Wednesday. The firm’s fifty day moving average price is $3.77 and its 200 day moving average price is $4.93. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85. The company has a market capitalization of $403.21 million, a price-to-earnings ratio of -1.99 and a beta of 3.59. ASP Isotopes Inc. has a 12-month low of $2.51 and a 12-month high of $14.49.

ASP Isotopes (NASDAQ:ASPI – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). The company had revenue of $5.12 million for the quarter, compared to analyst estimates of $4.47 million. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Wall Street Zen raised ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a research report on Monday, September 21st. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $13.00.

View Our Latest Research Report on ASPI

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ASPI. WINTON GROUP Ltd acquired a new stake in shares of ASP Isotopes in the 2nd quarter valued at $588,000. Integrated Wealth Concepts LLC acquired a new position in shares of ASP Isotopes during the second quarter valued at $176,000. Squarepoint Ops LLC boosted its stake in shares of ASP Isotopes by 75.6% in the 2nd quarter. Squarepoint Ops LLC now owns 123,951 shares of the company’s stock valued at $771,000 after purchasing an additional 53,354 shares during the last quarter. Amundi bought a new position in ASP Isotopes in the second quarter valued at approximately $107,000. Finally, AXQ Capital LP acquired a new stake in shares of ASP Isotopes during the second quarter worth $80,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage company focused on isotope enrichment and related technologies. The company is developing an isotope-separation platform known as the Aerodynamic Separation Process, which is intended to enrich selected chemical elements and isotopes for use in several specialized markets.

ASP Isotopes has identified applications in the nuclear energy, medical, semiconductor, and quantum-computing industries. Its development programs have included uranium enrichment as well as the production of specialty isotopes such as carbon-14, molybdenum-100, and silicon-28.

Featured Stories

Insider Buying and Selling by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.